Company Overview

Company name: Scopus BioPharma
Description: Developer of small molecule therapeutics leveraging in cannabinoid and cannabis research based in New York. The company is involved in lead selection and pre clinical testing of various gene therapy and hybrid medicinal compounds.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: | Code:
Employees: 2
State: New York
Country: United States

Financial Highlights

Start up capital raised (USD Million): 9.73
Business status: Clinical Trials – Phase 1
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2018
Financing Status:
Number of active investors:
Profile last updated: 23-Jul-2020
Last known valuation: 75.05
Last known valuation date: 05-Dec-2019